Letrozole combined with recombinant human growth hormone for Prader–Willi syndrome with concurrent central precocious puberty: an experimental therapeutic approach

Wujin Wang, Miao Huang, Guoqing Dong, Yongmei Zeng, Xiyan Lu

Open source

DOI
10.5603/ep.112910
Published
2026-09-08
Container
Endokrynologia Polska
Publisher
VM Media Group sp. z o.o
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5603/ep.112910,
  title = {Letrozole combined with recombinant human growth hormone for Prader–Willi syndrome with concurrent central precocious puberty: an experimental therapeutic approach},
  author = {Wujin Wang and Miao Huang and Guoqing Dong and Yongmei Zeng and Xiyan Lu},
  year = {2026},
  journal = {Endokrynologia Polska},
  doi = {10.5603/ep.112910},
  url = {https://doi.org/10.5603/ep.112910}
}

RIS

TY  - JOUR
TI  - Letrozole combined with recombinant human growth hormone for Prader–Willi syndrome with concurrent central precocious puberty: an experimental therapeutic approach
AU  - Wujin Wang
AU  - Miao Huang
AU  - Guoqing Dong
AU  - Yongmei Zeng
AU  - Xiyan Lu
PY  - 2026
JO  - Endokrynologia Polska
DO  - 10.5603/ep.112910
UR  - https://doi.org/10.5603/ep.112910
ER  - 

APA

Wang, W., Huang, M., Dong, G., Zeng, Y., & Lu, X. (2026). Letrozole combined with recombinant human growth hormone for Prader–Willi syndrome with concurrent central precocious puberty: an experimental therapeutic approach. Endokrynologia Polska. https://doi.org/10.5603/ep.112910

Source records